Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Return on Sales (2022 - 2025)

Envoy Medical's Return on Sales history spans 4 years, with the latest figure at 147.12% for Q3 2025.

  • For Q3 2025, Return on Sales fell 5358.0% year-over-year to 147.12%; the TTM value through Sep 2025 reached 107.73%, down 1325.0%, while the annual FY2024 figure was 89.21%, 3107.0% down from the prior year.
  • Return on Sales for Q3 2025 was 147.12% at Envoy Medical, down from 73.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 99.83% in Q3 2022 and bottomed at 147.12% in Q3 2025.
  • The 4-year median for Return on Sales is 83.39% (2024), against an average of 67.58%.
  • The largest annual shift saw Return on Sales crashed -14214bps in 2023 before it surged 41bps in 2025.
  • A 4-year view of Return on Sales shows it stood at 100.44% in 2022, then decreased by -17bps to 117.01% in 2023, then dropped by 0bps to 117.45% in 2024, then decreased by -25bps to 147.12% in 2025.
  • Per Business Quant, the three most recent readings for COCH's Return on Sales are 147.12% (Q3 2025), 73.0% (Q2 2025), and 121.78% (Q1 2025).